Progressive Retinal Atrophy (PRA) refers to a collection of inherited eye disorders that cause irreversible vision loss in dogs, including the Tibetan Spaniel. Among the various forms, PRA3 is specifically common in this breed and results in a gradual decline in sight without causing discomfort.
Awareness and understanding of PRA3 among Tibetan Spaniel owners and breeders in the U.S. are vital for managing this condition responsibly and safeguarding the breed's overall health.
PRA3 stems from a genetic mutation in the FAM161A gene, which plays a key role in maintaining the photoreceptor cells of the retina—the rods and cones responsible for detecting light and color. Find Tibetan Spaniel puppies from reputable U.S. breeders who conduct genetic testing for this condition.
This disease triggers ongoing deterioration of these critical cells, initially impacting rod cells which support night vision. Signs often become noticeable around 6 to 7 years of age, although subtle symptoms might be identified earlier by veterinary ophthalmologists. As the condition worsens, dogs lose both spatial and color vision, eventually becoming completely blind.
Symptoms develop slowly, commonly beginning with difficulty seeing in dim lighting. Owners might notice their dog becoming more cautious in low-light settings or occasionally bumping into furniture or obstacles. Vision impairment extends to daylight conditions over time, leading to full blindness.
Later stages may also involve secondary cataracts, but surgery to remove cataracts does not restore vision since the underlying retinal cells are damaged. While PRA3 is painless, it can seriously affect a dog's quality of life without suitable accommodations and care.
PRA3 is inherited as an autosomal recessive trait, meaning a dog must inherit two defective copies of the gene—one from each parent—to develop the condition. U.S. breeders rely on genetic testing to inform responsible breeding programs and reduce disease incidence. Find puppies with known genetic health through trusted breeders who perform genetic screening.
Here are the possible outcomes based on parental gene status:
About two-thirds of Tibetan Spaniels diagnosed with PRA in the U.S. have the PRA3 mutation. Studies suggest around 25% of Tibetan Spaniels may carry this mutation, whereas about 3% are clinically affected.
DNA testing through a simple cheek swab—taken by your veterinarian—is the standard approach for detecting the PRA3 mutation. Samples are sent to accredited veterinary genetics labs for analysis. Results classify dogs as clear, carriers, or affected, which informs breeders' mating decisions.
Given the mutation's frequency, breeders must carefully balance efforts to reduce PRA3 while maintaining genetic diversity to prevent other hereditary issues from arising.
No cure exists for PRA3 currently, so care focuses on aiding dogs to adjust to progressive vision loss. Owners can help by keeping their home environment consistent, using verbal or tactile cues for navigation, and ensuring safety both indoors and outdoors.
Veterinary ophthalmology can diagnose PRA early, helping owners plan for adaptations that preserve their dog’s wellbeing and comfort.
Progressive Retinal Atrophy 3 (PRA3) is an autosomal recessive, late-onset inherited retinal disease affecting Tibetan Spaniels, caused by a mutation in the FAM161A gene. It results in gradual vision loss and, ultimately, blindness. Responsible genetic testing and breeding reduce the risk of affected puppies, while supportive care enables affected dogs to maintain quality of life.
If you're considering welcoming a Tibetan Spaniel puppy into your home, be sure to choose reputable breeders who perform PRA3 genetic testing to ensure healthy, happy puppies and contribute to the breed's long-term welfare.